Novo Nordisk shares tumble as data on weight-loss drug trial disappoints
Unlock the Editor’s Digest for freeRoula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter.Novo Nordisk’s...
Unlock the Editor’s Digest for freeRoula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter.Novo Nordisk’s...
A total of 21 women participated in this consultation. Ages ranged from 50 to 80 with an average of 62...
Pfizer's experimental drug for a common, life-threatening condition that causes cancer patients to lose their appetite and weight showed positive...
Full details of the study design and outcomes from the parent study have been described elsewhere26. Here we briefly describe...